<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Cancer</journal-id><journal-title>BMC Cancer</journal-title><issn pub-type="epub">1471-2407</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2407-1-4</article-id><article-id pub-id-type="pmid">11389775</article-id><article-id pub-id-type="doi">10.1186/1471-2407-1-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Kongruttanachok</surname><given-names>Narisorn</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ruttiwan@hotmail.com</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Sukdikul</surname><given-names>Sairoong</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>sakdikul_s@hotmail.com</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Setavarin</surname><given-names>Surachai</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>bink506@hotmail.com</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Kerekhjanarong</surname><given-names>Verachai</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>Virachaik@hotmail.com</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Supiyaphun</surname><given-names>Pakpoom</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>fmedpsp@md2.md.chula.ac.th</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Voravud</surname><given-names>Narin</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>cu_medonco@hotmail.com</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Poovorawan</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>pyong@chula.ac.th</email></contrib><contrib id="A8" corresp="yes" contrib-type="author"><name><surname>Mutirangura</surname><given-names>Apiwat</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>mapiwat@chula.ac.th</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Anatomy, Chulalongkorn University, Bangkok, Thailand</aff><aff id="I2"><label>2</label>National Cancer Institute, Chulalongkorn University, Bangkok, Thailand</aff><aff id="I3"><label>3</label>Department of Otolaryngology, Chulalongkorn University, Bangkok, Thailand</aff><aff id="I4"><label>4</label>Medical Oncology unit, Chulalongkorn University, Bangkok, Thailand</aff><aff id="I5"><label>5</label>Viral Hepatitis Research Unit; Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand</aff><pub-date pub-type="collection"><year>2001</year></pub-date><pub-date pub-type="epub"><day>25</day><month>5</month><year>2001</year></pub-date><volume>1</volume><fpage>4</fpage><lpage>4</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2407/1/4"/><history><date date-type="received"><day>16</day><month>2</month><year>2001</year></date><date date-type="accepted"><day>25</day><month>5</month><year>2001</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2001 Kongruttanachok et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-statement><copyright-year>2001</copyright-year><copyright-holder>Kongruttanachok et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.</copyright-holder></permissions><abstract><sec><title>Background</title><p>Nasopharyngeal carcinoma (NPC) is a rare tumor in most parts of the world but occurs at relatively high frequency among people of Chinese descent. The cytochrome P450 2E1 enzyme (CYP2E1) is responsible for the metabolic activation of nitrosamines, and has been shown to be a susceptibility gene for NPC development in Taiwan [RR = 2.6; 95%CI = 1.2-5.7]. Since there has been only one report of this link, it was decided to investigate the susceptibility of <italic>CYP2E1</italic> to NPC development in other populations. Therefore, the correlation between the <italic>RsaI</italic> polymorphism of this gene and NPC was studied in-patients including Thai and Chinese in Thailand. The present study comprised 217 cases diagnosed with NPC and 297 healthy controls.</p></sec><sec><title>Results</title><p>Similar to the result found in Taiwanese, a homozygous uncut genotype demonstrated a higher relative risk both when all cases were analyzed [RR = 2.19; 95%CI = 0.62-8.68] or individual racial groups, Thai [RR = 1.51; 95%CI = 0.08-90.06] or Chinese [RR = 1.99; 95%CI = 0.39-10.87]. The ethnicity-adjusted odds ratio is 2.39 with 95%CI, 0.72-7.89.</p></sec><sec><title>Conclusions</title><p>Though our finding was not statistically significant due to the moderate sample size of the study, similarity to the study in Taiwan with only a slight loss in precision was demonstrated. The higher RR found for the same genotype in distinct populations confirmed that <italic>CYP2E1</italic> is one of several NPC susceptibility genes and that the RsaI minus variant is one mutation that affects phenotype.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Nasopharyngeal carcinoma (NPC) is a rare tumor in most parts of the world, with annual age-standardized incidence rates typically below 1 per 100,000 people/year in both sexes [<xref ref-type="bibr" rid="B1">1</xref>]. The tumor occurs most often in Southern Chinese who reside in Guangdong Province, at an incidence rate 30-50 per 100,000 people/year, in contrast with &#x0003c;1 per 100,000 people/year in white Europeans [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. The disease also occurs at moderate frequencies (3-10 per 100,000 people/year) in several non-Chinese ethnic groups such as Malay, Thai and Vietnamese [<xref ref-type="bibr" rid="B6">6</xref>]. Numerous factors, both environmental and genetic, have been associated with the risk of developing NPC. The environmental factors include infection with the Epstein-Barr virus (EBV), as well as frequent consumption of high levels of nitrosamine from preserved food such as salted fish [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. In addition, host factors also play a major role in NPC development. Unique alleles of the human leukocyte antigen (<italic>HLA</italic>) and cytochrome P450 2E1 (<italic>CYP2E1</italic>) have been shown to be associated with high relative risk in several Asian ethnic groups, including the Chinese in Taiwan [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>].</p><p>CYP2E1, an enzyme involved in the metabolic activation of procarcinogens into reactive intermediates capable of forming adducts and damaging DNA, is believed to play an essential role in chemical carcinogenesis [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>]. Nitrosamine is a substrate of CYP2E1. It is believed that nitrosamine, once activated can lead to the development of numerous cancers [<xref ref-type="bibr" rid="B15">15</xref>]. Studies have also demonstrated that <italic>CYP2E1</italic> is expressed in the nasal epithelium of human [<xref ref-type="bibr" rid="B16">16</xref>]. Evidence from previous epidemiological studies has suggested that salted fish is a food preferred by Chinese people and contains nitrosamines and nitrosamine precursors [<xref ref-type="bibr" rid="B9">9</xref>]. Therefore, <italic>CYP2E1</italic> is believed to render the nasopharyngeal epithelium susceptible to NPC development. A previous study in Taiwan employed a PCR-RFLP (polymerase chain reaction-restriction fragment length polymorphism) assay using the restriction enzyme <italic>RsaI</italic> in order to compare wild-type (+/+) and variant forms (-/-) of the <italic>CYP2E1</italic> gene between NPC patients and the general population [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. The variant form of contains <italic>CYP2E1</italic> polymorphic mutations in the distal 5'-flanking region of the gene, causing a marked difference in its transcriptional activity, as shown by CAT (chloramphenicol acetyltransferase) [<xref ref-type="bibr" rid="B17">17</xref>]. The Taiwanese association study showed that individuals homozygous for the variant allele (-/-) were at an increased risk for NPC development (relative risk [RR] = 2.6; 95% confidence interval [CI] = 1.2-5.7) [<xref ref-type="bibr" rid="B11">11</xref>]. There are many Chinese people who have immigrated and permanently lived in Thailand for 2 to 3 generations, resulting in a mixed population of Thai and Chinese people. From clinical observation, we had observed at least one-third of NPC patients were Chinese in origin. Since the susceptibility of <italic>CYP2E1</italic> gene to develop NPC had only been reported from Chinese people in Taiwan, it was decided to investigate whether this allele played the same role in other populations. Therefore, we studied the correlation of the polymorphism of the <italic>CYP2E1</italic> gene with NPC in Thai and Chinese populations in Thailand.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title>Sample collection</title><p>Blood samples were obtained by venipuncture from 217 NPC patients at Chulalongkorn Hospital and 297 healthy blood donors. All subjects were interviewed and separated into two groups, Thai and Chinese, based on their grandparents' ethnic origin. When their ancestors, including their great grandparents, originated from China, the patients were considered Chinese. When their ancestors originated from Thailand, the patients were considered Thai. There were 99 Thai and 98 Chinese in the control group. The NPC patient group included 132 Thai and 56 Chinese.</p></sec><sec><title>PCR-RFLP analysis</title><p>Genomic DNA (0.1 &#x003bc;g) extracted from leukocytes was used for each PCR analysis. The amplification was performed with primers as described previously by Hayashi et al. The total reaction volume of 50 &#x003bc;l consisted of 20 &#x003bc;M Tris-HCl (pH 8.4), 50 mM KCl, 1.5 mM MgCl<sub>2</sub>, 125 &#x003bc;M deoxynucleoside triphosphate, 0.2 &#x003bc;M primers, 4 U Taq DNA polymorase (Gibco), and 0.2 &#x003bc;g of template DNA. The PCR conditions were 40 cycles at 92&#x000b0;C for 1 minute, 60&#x000b0;C for 1 minute and 72 for 2 minutes in a Perkin-Elmer/DNA thermal Cycle 480. Genotypes of <italic>CYP2E1</italic> gene were determined by RFLP analysis. Twenty microliters of PCR products were digested with 10 U <italic>RsaI</italic> restriction enzyme (New England Biolabs) overnight at 37&#x000b0;C. The restricted products were analyzed by electrophoresis on 2% agarose gel. Bands were visualized with an ultraviolet transilluminator after ethidium bromide staining.</p></sec><sec><title>Statistical Analysis</title><p>The relative risk (RR) was estimated by the odds ratio method, to determine the correlation between genotype of the <italic>CYP2E1</italic> gene and NPC development. In addition, the RR was used to estimate the association of the pattern of genetic inheritance of the <italic>CYP2E1</italic> gene and NPC phenotype. The 95% confidence interval (CI) was computed to determine the statistical significance of the findings. The RR and 95%CI was calculated by using Exact method from Epit info version6 program.</p></sec></sec><sec><title>Results</title><p>In the present study, we investigated the correlation between the polymorphism of the <italic>CYP2E1</italic> gene and NPC on a total of 217 patients and 297 controls. The diagnosis of NPC was confirmed histologically and by the presence of EBV DNA in the tumor. PCR-RFLP analysis was used to evaluate <italic>RsaI</italic> polymorphism in the <italic>CYP2E1</italic> gene (fig <xref ref-type="fig" rid="F1">1</xref>). The distribution of alleles in all, Thai and Chinese were found to be in Hardy-Weinberg equilibrium. The calculated frequencies of heterozygous using 2x(+/+)<sup>1/2</sup> x (-/-)<sup>1/2</sup> were 0.32, 0.26, 0.42 from all, Thai, and Chinese NPC patients, and 0.32, 0.26 and 0.42 from all, Thai and Chinese control, respectively. These numbers are similar to actual frequencies of heterozygous from all groups, 0.32,0.28,0.42,0.35,0.28,0.52 from all, Thai and Chinese patients and all, Thai and Chinese control, respectively. We found the relative risk of the variant form (-/-) of the <italic>CYP2E1</italic> gene at a high risk [RR = 2.19]. However, this result had no statistical significance [95%CI = 0.62-8.68]. To evaluate whether the lack of significance of the trend was due to a mixed genetic background, both patients and controls were analyzed according to the origins of their ancestors (Thai or Chinese). A slightly increased risk of the variant from (-/-) of the <italic>CYP2E1</italic> gene could be demonstrated in both the Thai and Chinese sample groups [RR = 1.51; 95%CI = 0.08-90.06, RR = 1.99; 95%CI = 0.39-10.87, respectively]. Nevertheless, no statistical significance could be established. The estimated crude odds ratio lies outside of two ethnicity-specific odds ratios for Thai and Chinese indicates ethnicity is a confounder in this genotype-phenotype association. Odds ratio for the combined group of subjects with ethnicity information can be calculated with adjustment for ethnicity. The ethnicity-adjusted odds ratio (-/- vs +/-) is 1.86 (95%CI = 0.55-6.31). A similar adjustment using the whole sample of three groups, Thai, Chinese, and ethnicity unspecified showed an odd ratio of 2.39, with only a slight loss in precision (95%CI = 0.72-7.89). This is closer to the odds ratio of 2.6 from the study in Taiwan. Furthermore, Thai-Taiwanese comparison was done quantitatively by testing H0:OR(Thai)=OR(Taiwan). Using Mantel-Haenszel test for odds ratio homogeneity, the p-value was 0.81. Thus there is no statistical different for the role of <italic>CYP2E1</italic> on NPC development between these two populations.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>PCR-RFLP assay to detect the polymorphism of the <italic>CYP2E1</italic> gene by <italic>RsaI</italic> enzyme digesting the 410 bp PCR product into 360 bp and 50 bp fragments. Lane 1, homozygous variant (-/-); Lane 2, heterozygous (+/-); Lane 3, homozygous wild type (+/+).</p></caption><graphic xlink:href="1471-2407-1-4-1"/></fig><p>In this study, we further analyzed the association of the pattern of genetic inheritance of <italic>CYP2E1</italic> gene and NPC phenotype by calculating the relative risk if the genotype were either autosomal dominant (AD) or autosomal recessive (AR). In autosomal dominance, the contribution of a single variant allele would show a higher RR. Thus the RR for the combination of the heterozygous (+/-) and the variant form (-/-) compared with wild type (+/+) were computed. There was no association between AD heredity and NPC risk in the total, Thai, and Chinese sample groups [RR = 1.00; 95%CI = 0.68-1.47, RR = 1.01; 95%CI = 0.55-1.87, RR = 0.84; 95%CI = 0.41-1.71, respectively] (Table <xref ref-type="table" rid="T2">2</xref>). By contrast, AR inheritance requires an abnormality in both alleles of the <italic>CYP2E1</italic> gene. The RR were calculated by comparison between the wild type (+/+), the heterozygous (+/-) or the combination of the wild type and heterozygous (+/+ and +/-) and the variant form (-/-). A higher RR value in all comparisons was shown for AR heredity in all sample groups (Table <xref ref-type="table" rid="T3">3</xref>). However, these results showed no statistical significance for either the AD or AR pattern.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Frequency distribution and relative risks associated with genotype variants of<italic>CYP2E1</italic> detected RFLP using RsaI</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">CYP2E1</td><td align="center" colspan="2">Frequency</td><td align="center">RR</td><td align="center">95%CI</td></tr><tr><td></td><td colspan="2"><hr></hr></td><td></td><td></td></tr><tr><td></td><td align="center">Cases</td><td align="center">Controls</td><td></td><td></td></tr></thead><tbody><tr><td align="left"><bold>Total</bold></td><td align="right"><bold>217<sup>*</sup></bold></td><td align="right"><bold>297</bold></td><td></td><td></td></tr><tr><td align="left">+ / +</td><td align="right">138</td><td align="right">189</td><td align="center">1.00</td><td></td></tr><tr><td align="left">+ / -</td><td align="right">71</td><td align="right">103</td><td align="center">0.94</td><td align="center">0.64 - 1.39</td></tr><tr><td align="left">- / -</td><td align="right">8</td><td align="right">5</td><td align="center">2.19</td><td align="center">0.62 - 8.68</td></tr><tr><td align="left"><bold>Thai</bold></td><td align="right"><bold>132</bold></td><td align="right"><bold>99</bold></td><td></td><td></td></tr><tr><td align="left">+ / +</td><td align="right">93</td><td align="right">70</td><td align="center">1.00</td><td></td></tr><tr><td align="left">+ / -</td><td align="right">37</td><td align="right">28</td><td align="center">0.99</td><td align="center">0.54 - 1.86</td></tr><tr><td align="left">- / -</td><td align="right">2</td><td align="right">1</td><td align="center">1.51</td><td align="center">0.08 - 90.06</td></tr><tr><td align="left"><bold>Chinese</bold></td><td align="right"><bold>56</bold></td><td align="right"><bold>98</bold></td><td></td><td></td></tr><tr><td align="left">+ / +</td><td align="right">27</td><td align="right">43</td><td align="center">1.00</td><td></td></tr><tr><td align="left">+ / -</td><td align="right">24</td><td align="right">51</td><td align="center">0.75</td><td align="center">0.36 - 1.57</td></tr><tr><td align="left">- / -</td><td align="right">5</td><td align="right">4</td><td align="center">1.99</td><td align="center">0.39 - 10.87</td></tr></tbody></table><table-wrap-foot><p><sup>*</sup> 29 cases lack precise information regrarding ethnicity +, The allele could be digested with <italic>RsaI</italic> enzyme -, The allele could not be digested with <italic>RsaI</italic> enzyme</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Correlation between Autosomal Dominant (AD) pattern of genetic<italic>CYP2E1</italic> gene and NPC phenotype</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">CYP2E1</td><td align="center" colspan="2">Frequency</td><td align="center">RR <sub>(<italic>AD</italic>)</sub></td><td align="center">95%CI</td></tr><tr><td></td><td colspan="2"><hr></hr></td><td></td><td></td></tr><tr><td></td><td align="center">Cases</td><td align="center">Controls</td><td></td><td></td></tr></thead><tbody><tr><td align="left"><bold>Total</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">+ / +</td><td align="right">138</td><td align="right">189</td><td align="center">1.00</td><td></td></tr><tr><td align="left">+ / - and - / -</td><td align="right">79</td><td align="right">108</td><td align="center">1.00</td><td align="center">0.68 - 1.47</td></tr><tr><td align="left"><bold>Thai</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">+ / +</td><td align="right">93</td><td align="right">70</td><td align="center">1.00</td><td></td></tr><tr><td align="left">+ / - and - / -</td><td align="right">39</td><td align="right">29</td><td align="center">1.01</td><td align="center">0.55 - 1.87</td></tr><tr><td align="left"><bold>Chinese</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">+ / +</td><td align="right">27</td><td align="right">43</td><td align="center">1.00</td><td></td></tr><tr><td align="left">+ / - and - / -</td><td align="right">29</td><td align="right">55</td><td align="center">0.84</td><td align="center">0.41 - 1.71</td></tr></tbody></table><table-wrap-foot><p>+, The allele could be digested with <italic>RsaI</italic> enzyme -, The allele could not be digested with <italic>RsaI</italic> enzyme</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Correlation between Autosomal Recessive (AR) pattern of genetic<italic>CYP2E1</italic> gene and NPC phenotype</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">CYP2E1</td><td align="center" colspan="2">Frequency</td><td align="center">RR <sub>(AR)</sub></td><td align="center">95%CI</td></tr><tr><td></td><td colspan="2"><hr></hr></td><td></td><td></td></tr><tr><td></td><td align="center">Cases</td><td align="center">Controls</td><td></td><td></td></tr></thead><tbody><tr><td align="left"><bold>Total</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">+ / +</td><td align="right">138</td><td align="right">189</td><td align="center">1.00</td><td></td></tr><tr><td align="left">- / -</td><td align="right">8</td><td align="right">5</td><td align="center">2.19</td><td align="center">0.62 - 8.68</td></tr><tr><td align="left">+ / -</td><td align="right">71</td><td align="right">103</td><td align="center">1.00</td><td></td></tr><tr><td align="left">- / -</td><td align="right">8</td><td align="right">5</td><td align="center">2.32</td><td align="center">0.64 - 9.36</td></tr><tr><td align="left">+ / + and + / -</td><td align="right">209</td><td align="right">292</td><td align="center">1.00</td><td></td></tr><tr><td align="left">- / -</td><td align="right">8</td><td align="right">5</td><td align="center">2.24</td><td align="center">0.63 - 8.80</td></tr><tr><td align="left"><bold>Thai</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">+ / +</td><td align="right">93</td><td align="right">70</td><td align="center">1.00</td><td></td></tr><tr><td align="left">- / -</td><td align="right">2</td><td align="right">1</td><td align="center">1.51</td><td align="center">0.08 - 90.06</td></tr><tr><td align="left">+ / -</td><td align="right">37</td><td align="right">28</td><td align="center">1.00</td><td></td></tr><tr><td align="left">- / -</td><td align="right">2</td><td align="right">1</td><td align="center">1.51</td><td align="center">0.07 - 92.44</td></tr><tr><td align="left">+ / + and + / -</td><td align="right">130</td><td align="right">98</td><td align="center">1.00</td><td></td></tr><tr><td align="left">- / -</td><td align="right">2</td><td align="right">1</td><td align="center">1.51</td><td align="center">0.08 - 89.84</td></tr><tr><td align="left"><bold>Chinese</bold></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">+ / +</td><td align="right">27</td><td align="right">43</td><td align="center">1.00</td><td></td></tr><tr><td align="left">- / -</td><td align="right">5</td><td align="right">4</td><td align="center">1.99</td><td align="center">0.39 - 10.87</td></tr><tr><td align="left">+ / -</td><td align="right">24</td><td align="right">51</td><td align="center">1.00</td><td></td></tr><tr><td align="left">- / -</td><td align="right">5</td><td align="right">4</td><td align="center">2.66</td><td align="center">0.51 - 14.48</td></tr><tr><td align="left">+ / + and + / -</td><td align="right">51</td><td align="right">94</td><td align="center">1.00</td><td></td></tr><tr><td align="left">- / -</td><td align="right">5</td><td align="right">4</td><td align="center">2.30</td><td align="center">0.47 - 12.08</td></tr></tbody></table><table-wrap-foot><p>+, The allele could be digested with <italic>RsaI</italic> enzyme -, The allele could not be digested with <italic>RsaI</italic> enzyme</p></table-wrap-foot></table-wrap></sec><sec><title>Discussion</title><p>We have shown an increased risk of developing NPC associated with the homozygous variant form of the <italic>CYP2E1</italic> gene. This higher RR was demonstrated in both the Thai and Chinese populations in Thailand. This finding was similar to the result reported from Taiwan. However, these results were marginal statistical significance, which may well be due to the small sample size employed in the present study. Thus the <italic>CYP2E1</italic> gene appears to be a susceptibility gene for NPC development regardless of the patient's genetic background. Patients of both Thai and Chinese ethnic origin revealed a higher relative risk from the same allele, despite their distinct ancestry. Thus it is more likely that the <italic>RsaI</italic> negative allele affects the phenotype directly rather than being a consequence of linkage disequilibrium from another mutation or gene. This confirms the previous finding that the polymorphic <italic>RsaI</italic> site was essential for a marked difference in transcriptional activities [<xref ref-type="bibr" rid="B17">17</xref>]. A higher level of expression in the variant form would result in larger amounts of procarcinogens being changed into carcinogens, that then produce DNA damage. The affect of the distinct expression level of a metabolic gene should be reduced if the person with abnormal genotype is not exposed to the substrate. For example, Phenylketonuria (PKU) patients would not demonstrate mental retardation if they were prevented completely from exposure to tyrosine [<xref ref-type="bibr" rid="B18">18</xref>]. In other words, a mutation can not cause the phenotype without interaction from environmental factors. Regarding NPC development, the role of <italic>CYP2E1</italic> variant may be varied upon the amount of consumed salted fish and/or preserved foods that contain nitrosamine and nitrosamine precursors.</p></sec><sec><title>Conclusion</title><p>Result of the reported crude odds ratio is 2.19 [95%CI = 0.62-8.68]. If the result is adjusted odds ratio, it will be 2.39 [95%CI = 0.72-7.89], which is closer to the Taiwanese odds ratio of 2.6, with only a slight loss in precision. Thus, this study confirmed a previous study in Taiwan that <italic>CYP2E1</italic> appears to be one of a number of NPC susceptibility genes and the RsaI minus variant is not just a polymorphism but directly influences the development of the phenotype.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/content/backmatter/1471-2407-1-4-b1.pdf"/></p></sec></body><back><ack><sec><title>Acknowledgments</title><p>We deeply indebted to the staff of the Department of Otolaryngology and the Radiotherapy Section, Department of Radiology, Chulalongkorn Hospital and National Blood Center for the recruitment of patients and collection of materials. This work was supported by Molecular Biology Project, Faculty of Medicine, Chulalongkorn University and the Thailand research Fund.</p><p>Competing interests</p><p>None declared</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parkin</surname><given-names>DM</given-names></name><name><surname>Muir</surname><given-names>CS</given-names></name></person-group><article-title>Cancer Incidence in Five Continents: Comparability and quality of data.</article-title><source>IARC Sci Publ</source><year>1992</year><volume>120</volume><fpage>45</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">1284606</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>MJ</given-names></name><name><surname>Wee</surname><given-names>GB</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Dharmalingham</surname><given-names>S</given-names></name><name><surname>Yong</surname><given-names>NK</given-names></name><name><surname>Chau</surname><given-names>JC</given-names></name><name><surname>Ho</surname><given-names>JH</given-names></name><name><surname>Day</surname><given-names>NE</given-names></name><name><surname>De The</surname><given-names>G</given-names></name></person-group><article-title>Immunogenetic aspects of nasopharyngeal carcinoma. V. Confirmation of a Chinese-related HLA profile (A2, Singapore 2) associated with an increased risk in Chinese for nasopharyngeal carcinoma.</article-title><source>Natl Cancer Inst Monogr</source><year>1977</year><volume>47</volume><fpage>147</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">613233</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>HY</given-names></name></person-group><article-title>Apparent correlation between nasopharyngeal carcinoma and HLA phenotype.</article-title><source>Chung Hua Chung Liu Tsa Chih</source><year>1982</year><volume>4(4)</volume><fpage>249</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">7166103</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>SH</given-names></name></person-group><article-title>Aetiology of nasopharyngeal carcinoma.</article-title><source>Ann Acad Med Singapore</source><year>1990</year><volume>19(2)</volume><fpage>201</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">2189340</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>XN</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Kong</surname><given-names>FH</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name></person-group><article-title>Human leukocyte antigens -A, -B, -C, and -DR and nasopharyngeal carcinoma in northern China.</article-title><source>Ann Otol Rhinol Laryngol</source><year>1990</year><volume>99(4 Pt 1)</volume><fpage>286</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">2327697</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muir</surname><given-names>CS</given-names></name></person-group><article-title>Nasopharyngeal carcinoma in non-Chinese populations with special reference to south-east Asia and Africa.</article-title><source>Int J Cancer</source><year>1971</year><volume>15</volume><fpage>351</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">4332898</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>PH</given-names></name><name><surname>Suen</surname><given-names>MW</given-names></name><name><surname>Huang</surname><given-names>DP</given-names></name><name><surname>Lo</surname><given-names>KW</given-names></name><name><surname>Lee</surname><given-names>JC</given-names></name></person-group><article-title>Nasopharyngeal carcinoma: genetic changes, Epstein-Barr virus infection, or both. A clinical and molecular study of 36 patients.</article-title><source>Cancer</source><year>1993</year><volume>15</volume><fpage>2873</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8106138</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hildesheim</surname><given-names>A</given-names></name><name><surname>Levine</surname><given-names>PH</given-names></name></person-group><article-title>Etiology of nasopharyngeal carcinoma: a review.</article-title><source>Epidemiol</source><year>1993</year><volume>15(2)</volume><fpage>466</fpage><lpage>85</lpage></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>YM</given-names></name><name><surname>Tuppin</surname><given-names>P</given-names></name><name><surname>Hubert</surname><given-names>A</given-names></name><name><surname>Jeannel</surname><given-names>D</given-names></name><name><surname>Pan</surname><given-names>YJ</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>de The</surname><given-names>G</given-names></name></person-group><article-title>Environmental and dietary risk factors for nasopharyngeal carcinoma: a case-control study in Zangwu County, Guangxi, China.</article-title><source>Br JCancer</source><year>1994</year><volume>69(3)</volume><fpage>508</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">8123482</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hildesheim</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>CJ</given-names></name><name><surname>Caporaso</surname><given-names>NE</given-names></name><name><surname>Cheng</surname><given-names>YJ</given-names></name><name><surname>Hoover</surname><given-names>RN</given-names></name><name><surname>Hsu</surname><given-names>MM</given-names></name><name><surname>Levine</surname><given-names>PH</given-names></name><name><surname>Chen</surname><given-names>IH</given-names></name><name><surname>Chen</surname><given-names>JY</given-names></name><name><surname>Yang</surname><given-names>CS</given-names></name><etal></etal></person-group><article-title>Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan.</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>1995</year><volume>4(6)</volume><fpage>607</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">8547826</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hildesheim</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>LM</given-names></name><name><surname>Chen</surname><given-names>CJ</given-names></name><name><surname>Cheng</surname><given-names>YJ</given-names></name><name><surname>Brinton</surname><given-names>LA</given-names></name><name><surname>Daly</surname><given-names>AK</given-names></name><name><surname>Reed</surname><given-names>CD</given-names></name><name><surname>Chen</surname><given-names>IH</given-names></name><name><surname>Caporaso</surname><given-names>NE</given-names></name><name><surname>Hsu</surname><given-names>MM</given-names></name><etal></etal></person-group><article-title>CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan.</article-title><source>J Natl Cancer Inst</source><year>1997</year><volume>20;89(16)</volume><fpage>1207</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">9274915</pub-id><pub-id pub-id-type="doi">10.1093/jnci/89.16.1207</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nebert</surname><given-names>DW</given-names></name></person-group><article-title>Role of genetics and drug metabolism in human cancer risk.</article-title><source>Mutat Res</source><year>1991</year><volume>247(2)</volume><fpage>267</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">2011144</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poulsen</surname><given-names>HE</given-names></name><name><surname>Loft</surname><given-names>S</given-names></name><name><surname>Wassermann</surname><given-names>K</given-names></name></person-group><article-title>Cancer risk related to genetic polymorphisms in carcinogen metabolism and DNA repair.</article-title><source>Pharmacol Toxicol</source><year>1993</year><volume>72 Suppl 1</volume><fpage>93</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">8474997</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bartsch</surname><given-names>H</given-names></name><name><surname>Montesano</surname><given-names>R</given-names></name></person-group><article-title>Relevance of nitrosamines to human cancer.</article-title><source>Carcinogenesis</source><year>1984</year><volume>5(11)</volume><fpage>1381</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">6386215</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gervasi</surname><given-names>PG</given-names></name><name><surname>Longo</surname><given-names>V</given-names></name><name><surname>Naldi</surname><given-names>F</given-names></name><name><surname>Panattoni</surname><given-names>G</given-names></name><name><surname>Ursino</surname><given-names>FX</given-names></name></person-group><article-title>enobiotic-metabolizing enzymes in human respiratory nasal mucosa.</article-title><source>Biochem Pharmacol</source><year>1991</year><volume>15;41(2)</volume><fpage>177</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">1989628</pub-id><pub-id pub-id-type="doi">10.1016/0006-2952(91)90474-J</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poirier</surname><given-names>S</given-names></name><name><surname>Bouvier</surname><given-names>G</given-names></name><name><surname>Malaveille</surname><given-names>C</given-names></name><name><surname>Ohshima</surname><given-names>H</given-names></name><name><surname>Shao</surname><given-names>YM</given-names></name><name><surname>Hubert</surname><given-names>A</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>de The</surname><given-names>G</given-names></name><name><surname>Bartsch</surname><given-names>H</given-names></name></person-group><article-title>Volatile nitrosamine levels and genotoxicity of food samples from high-risk areas for nasopharyngeal carcinoma before and after nitrosation.</article-title><source>Int J Cancer</source><year>1989</year><volume>5;44(6)</volume><fpage>1088</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">2558079</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>J</given-names></name><name><surname>Kawajiri</surname><given-names>K</given-names></name></person-group><article-title>Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene.</article-title><source>J Biochem (Tokyo)</source><year>1991</year><volume>110(4)</volume><fpage>559</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">1778977</pub-id></citation></ref><ref id="B18"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Bruce</surname><given-names>RK</given-names></name></person-group><article-title>Human Genetics: A problem-Based Approach.</article-title><source>Massachusetts: Blackwell Science</source><year>1999</year></citation></ref></ref-list></back></article> 